QuickView for energy coupled proton transmembrane transport, against electrochemical gradient (biogroup)

1. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
2. L1000 CMAP - Cervical cancer HELA.311 cells with CRISPR induced gene knockouts
3. L1000 CMAP - Hepatocellular carcinoma HEPG2 cells treated with small molecule perturbagens
4. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
5. L1000 CMAP - Neural progenitor NPC cells treated with small molecule perturbagens

There were no matches for energy coupled proton transmembrane transport, against electrochemical gradient

There were no clinical trials for energy coupled proton transmembrane transport, against electrochemical gradient